- Report of Foreign Issuer (6-K)
March 15 2012 - 1:39PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF
1934
Date: March 15, 2012
Commission File Number: 1-15060
UBS AG
(Registrant’s Name)
Bahnhofstrasse 45, Zurich, Switzerland, and
Aeschenvorstadt 1, Basel,
Switzerland
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F
x
Form 40-F
¨
Capitalization of UBS
The following table presents the consolidated capitalization of UBS in accordance with International Financial Reporting Standards (IFRS) and translated into US dollars.
Capitalization of UBS
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
|
As of
|
|
|
|
|
31.12.2011
|
|
|
30.09.2011
|
|
|
in million
|
|
CHF
|
|
|
USD
|
|
|
CHF
|
|
|
USD
|
|
|
Debt
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short term debt issued
1
|
|
|
95,241
|
|
|
|
101,496
|
|
|
|
89,516
|
|
|
|
98,772
|
|
|
Long term debt issued
1
|
|
|
120,435
|
|
|
|
128,344
|
|
|
|
116,395
|
|
|
|
128,430
|
|
|
Total debt issued
1
|
|
|
215,675
|
|
|
|
229,840
|
|
|
|
205,911
|
|
|
|
227,203
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity attributable to UBS shareholders
|
|
|
53,447
|
|
|
|
56,957
|
|
|
|
51,817
|
|
|
|
57,175
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity attributable to Non-controlling interests
2
|
|
|
4,406
|
|
|
|
4,695
|
|
|
|
4,458
|
|
|
|
4,919
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total capitalization
|
|
|
273,527
|
|
|
|
291,492
|
|
|
|
262,187
|
|
|
|
289,297
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
Includes Money Market Paper and
Medium Term Notes as per Balance sheet position based on remaining maturities.
2
Includes preferred securities.
|
Swiss franc (CHF) amounts as of 31 December 2011 have been translated into U.S. dollars (USD) at the rate of CHF 1 = USD 1.06568 (the exchange rate in effect as of 31 December 2011), and CHF
amounts as of 30 September 2011 have been translated into USD at the rate of CHF 1 = USD 1.10340 (the exchange rate in effect as of 30 September 2011).
This Form 6-K is hereby incorporated by reference into (1) each of the registration
statements of UBS AG on Form F-3 (Registration Number 333-178960) and Form S-8 (Registration Numbers 333-49210; 333-49212; 333-127183; 333-127184; 333-162798; 333-162799; 333-162800; 333-178539; 333-178540; 333-178541; and 333-178543)
and into each prospectus outstanding under any of the foregoing registration statements, (2) any outstanding offering circular or similar document issued or authorized by UBS AG that incorporates by reference any Form 6-K’s of
UBS AG that are incorporated into its registration statements filed with the SEC, and (3) the base prospectus of Corporate Asset Backed Corporation (“CABCO”) dated June 23, 2004 (Registration Number 333-111572), the
Form 8-K of CABCO filed and dated June 23, 2004 (SEC File Number 001-13444), and the Prospectus Supplements relating to the CABCO Series 2004-101 Trust dated May 10, 2004 and May 17, 2004 (Registration
Number 033-91744 and 033-91744-05).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
UBS AG
|
|
|
|
|
By:
|
|
/s/ Louis Eber
|
|
|
|
Name: Louis Eber
|
|
|
|
Title: Group Managing Director
|
|
|
|
|
|
By:
|
|
/s/ Sarah M. Starkweather
|
|
|
|
Name: Sarah M. Starkweather
|
|
|
|
Title: Director
|
Date: March 15, 2012
THC Farmaceuticals (PK) (USOTC:CBDG)
Historical Stock Chart
From Jun 2024 to Jul 2024
THC Farmaceuticals (PK) (USOTC:CBDG)
Historical Stock Chart
From Jul 2023 to Jul 2024
